Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Gritstone bio, Inc.
  6. Company
    GRTS   US39868T1051

GRITSTONE BIO, INC.

(GRTS)
  Report
Delayed Nasdaq  -  04:00 2022-06-30 pm EDT
2.420 USD   -1.63%
06/24GRITSTONE BIO, INC.(NASDAQGS : GRTS) dropped from Russell Small Cap Comp Value Index
CI
06/24GRITSTONE BIO, INC.(NASDAQGS : GRTS) dropped from Russell 2000 Value Index
CI
06/24GRITSTONE BIO, INC.(NASDAQGS : GRTS) dropped from Russell 3000E Value Index
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Gritstone bio, Inc.
Gritstone bio, Inc. is a biotechnology company. The Company discover, develop, manufacture and deliver next generation cancer and infectious disease immunotherapy candidates by vaccine vectors, self-amplifying mRNA (samRNA) and chimpanzee adenovirus (ChAd). Its two oncology programs in clinical-stage development are GRANITE, individualized neoantigen-based immunotherapy, and SLATE, an off-the-shelf shared neoantigen-based immunotherapy. The Company has an infectious disease pipeline, which includes two programs in clinical-stage development: CORAL, a second-generation COVID-19 vaccine program that may have pan-coronavirus potential to protect against future coronavirus pandemics, and an HIV therapeutic/cure vaccine candidate that are collaborating on with Gilead Sciences, Inc. The Company’s product candidates include GRT-C907 (ChAd)/R908 (samRNA), GRT- C909 (ChAd)/R910 (samRNA), GRT-C909 (ChAd)/R910 (samRNA), GRT-R914 (samRNA), GRT-R912 (samRNA) and GRT-R918 (samRNA).

Number of employees : 193 people.
Sales per Business
20202021Delta
Immunotherapies for Cancer and Infectious Disease4.04100%48.21100% +1094.3%
USD in Million
Sales per region
20202021Delta
United States4.04100%48.21100% +1094.3%
USD in Million
Managers
Name Title Age Since
Andrew R. Allen, Dr. President, Chief Executive Officer & Director 54 2021
Vassiliki Celia Economides Chief Financial Officer & Executive Vice President 41 2021
Karin Jooss, Dr. Head-Research & Development 56 2021
Erin E. Jones Chief Operating Officer 49 2021
George E. MacDougall Director-Investor Relations & Communications - 2021
Vijay Yabannavar, Dr. Chief Technical Development Officer & Executive VP 60 -
Matthew Hawryluk, Dr. Chief Business Officer & Executive Vice President 43 2015
Rahsaan W. Thompson Executive Vice President & General Counsel 50 2020
Stacy Lea Proctor Senior Vice President & Head-People - -
James Cho Chief Accounting Officer - 2021
Members of the board
Name Title Age Since
Elaine V. Jones, Dr. Chairman 66 2020
Richard A. Heyman, Dr. Vice Chairman 63 -
Steve Krognes Independent Director 52 2018
Shefali Agarwal, Dr. Independent Director 47 2021
Naiyer A. Rizvi, Dr. Independent Director - 2021
Clare Fisher Independent Director - 2022
Andrew R. Allen, Dr. President, Chief Executive Officer & Director 54 2021
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 72,812,833 70,647,570 97.0% 0 0.0% 97.0%
Shareholders
NameEquities%
Redmile Group LLC 6,871,738 9.44%
Ecor1 Capital LLC 6,012,232 8.26%
Frazier Life Sciences Management LP 5,237,348 7.19%
Frazier Management LLC 4,667,242 6.41%
Versant Venture Management LLC 3,561,150 4.89%
Deep Track Capital LP 2,985,729 4.10%
The Vanguard Group, Inc. 2,692,367 3.70%
Clarus Ventures LLC 2,567,445 3.53%
Palo Alto Investors LP 2,330,504 3.20%
Casdin Capital LLC 1,850,373 2.54%
Brand Portfolio
In partnership withAllbrands.markets
More brands of Gritstone bio, Inc.
Analysis
AstraZeneca : invests in Imperial's self-amplifying RNA technology with eye on future drugs
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Biopharmaceuticals
Sector Biopharmaceuticals
1st jan.Capi. (M$)
GRITSTONE BIO, INC.-80.87%179
CSL LIMITED-7.20%89 344
SAMSUNG BIOLOGICS CO.,LTD.-12.51%43 874
WUXI BIOLOGICS (CAYMAN) INC.-21.50%39 065
BIOGEN INC.-14.46%30 056
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.-10.91%26 146
UCB-18.17%16 265
BIOMARIN PHARMACEUTICAL INC.-5.01%15 525
WALVAX BIOTECHNOLOGY CO., LTD.-13.90%11 152
GRIFOLS, S.A.0.68%10 398
BLOOMAGE BIOTECHNOLOGY CORPORATION LIMITED-8.45%9 820
SHANGHAI JUNSHI BIOSCIENCES CO., LTD.-26.47%8 907
CELLTRION HEALTHCARE CO., LTD.-14.46%8 034
SHENZHEN KANGTAI BIOLOGICAL PRODUCTS CO., LTD.-26.64%7 388
SK BIOSCIENCE CO.,LTD.-55.33%6 441
INNOVENT BIOLOGICS, INC.-29.43%6 365
SWEDISH ORPHAN BIOVITRUM AB (PUBL)18.64%6 347
HUALAN BIOLOGICAL ENGINEERING INC.-21.76%6 164
BEIJING TIANTAN BIOLOGICAL PRODUCTS CO., LTD.-16.16%4 980
CANSINO BIOLOGICS INC.-54.91%4 847
APELLIS PHARMACEUTICALS, INC.-4.42%4 814
Connections : Gritstone bio, Inc.